CD274 and small cell lung carcinoma: Typically, in patients with extensive-stage SCLC, an anti-programmed cell death ligand 1 (PD-L1) immune checkpoint inhibitor (ICI) is administered in combination with chemotherapies [National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines).